About
ReAx is developing a next-generation chemoproteomics platform that leverages chemical and biological insights to identify and target novel hotspots across the proteome in disease-relevant contexts, enabling target discovery for therapeutics development.
Explore ReAx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.